Despite recent advances, there continue to be significant issues that compromise the effective management of pulmonary arterial hypertension, writes Victoria Allan.
Victoria Allan
Advertisement
Victoria Allan is Head of Cardiovascular/Respiratory Therapy Monitors, Ipsos Healthcare.
Articles by Victoria Allan
Advertisement
Latest Updated Articles
Why Is It Such a Challenge to Treat PAH?Published: July 3rd 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
